Karen Denne, 310-954-5058, firstname.lastname@example.org
Nicole M. Davis, email@example.com
Broad Institute of MIT and Harvard announces board of directors
New board members committed to “wise and effective stewardship” for Broad
CAMBRIDGE, MASS., Oct. 8, 2009—The Broad Institute of MIT and Harvard today announced the members of its first board of directors.
“These individuals, all of them recognized as world leaders in science, medicine, education, finance, law, and business, have joined cause to help us fulfill our ambitious mission to accelerate progress in biomedicine through new approaches to science and scientific community,” said Eric S. Lander, president and director of the Broad Institute. “We are absolutely delighted by their commitment to provide wise and effective stewardship for the Broad Institute in this exciting new stage of its growth.”
The members of the Broad Institute’s first board of directors include:
- Dennis Ausiello
Chief of Medicine at Massachusetts General Hospital
- David Baltimore
President emeritus, California Institute of Technology; Nobel Laureate
- Eli Broad
Founder, The Broad Foundations
- Drew Gilpin Faust
President, Harvard University
- Jeffrey S. Flier
Dean of the Faculty of Medicine, Harvard Medical School
- Susan Hockfield
President, Massachusetts Institute of Technology
- Seth A. Klarman
President, The Baupost Group, LLC
- Eric S. Lander
President and Director of the Broad Institute; Professor, MIT; Professor, Harvard Medical School
- William F. Lee
Co-managing Partner, WilmerHale
- Arthur D. Levinson
Chairman, Genentech, Inc.
- Phillip A. Sharp
Institute Professor, Massachusetts Institute of Technology; Nobel Laureate
- Patty Stonesifer
Former President, Bill & Melinda Gates Foundation; Senior Advisor to the Trustees of the Bill & Melinda Gates Foundation
- Ratan N. Tata
Chairman of Tata Group
- Diana Chapman Walsh
President emerita, Wellesley College
The Broad Institute was founded in 2003 and launched in 2004 by MIT, Harvard, and the Broad Foundations to be a new kind of research institution aimed at propelling the transformation of medicine by empowering a new generation of scientists to work together to apply powerful new technologies and approaches to the understanding and treatment of disease. Declared a success by its founders after only four years, Eli and Edythe Broad announced in 2008 their intent to endow the institute, enabling it to transition to a permanent non-profit research institution — with its own board of directors in July 2009. Today, Broad brings together more than 100 faculty and over 1500 scientists from across MIT, Harvard, and the Harvard-affiliated hospitals — and beyond to tackle ambitious and important challenges in biomedicine.
Members of the Broad Institute Board of Directors are appointed for three-year terms.
About the Broad Institute of MIT and Harvard
The Eli and Edythe L. Broad Institute of MIT and Harvard was founded in 2003 to empower this generation of creative scientists to transform medicine with new genome- based knowledge. The Broad Institute seeks to describe all the molecular components of life and their connections; discover the molecular basis of major human diseases; develop effective new approaches to diagnostics and therapeutics; and disseminate discoveries, tools, methods and data openly to the entire scientific community.
Founded by MIT, Harvard and its affiliated hospitals, and the visionary Los Angeles philanthropists Eli and Edythe L. Broad, the Broad Institute includes faculty, professional staff and students from throughout the MIT and Harvard biomedical research communities and beyond, with collaborations spanning over a hundred private and public institutions in more than 40 countries worldwide. For further information about the Broad Institute, go to www.broadinstitute.org.
# # #